Publication | Closed Access

Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing–remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide

Immune RegulationImmunologyImmunotherapyImmune DysregulationNeuroinflammationAutoantibodiesNeurologyNeuroimmunologyAnti-il-12 AntibodyAutoimmune DiseaseBrain-immune InteractionAutoimmunityHumoral ImmunityImmune FunctionNod MiceImmunologic DiseaseCell BiologyImmune Cell DevelopmentMultiple SclerosisMedicine